More on ICCC
Data
Financials
Upcoming Events
News
Click line-items for a historical chart and %
| Product sales | 1.97M |
| Costs of goods sold | 763.5K |
| Gross margin | 1.2M |
| Product development expenses | 307.72K |
| Administrative expenses | 362.73K |
| Sales and marketing expenses | 483.71K |
| Other operating expenses | 1.15M |
| NET OPERATING LOSS | 50.47K |
| Other (expenses) revenues, net | |
| LOSS BEFORE INCOME TAXES | 23.96K |
| Income tax benefit | -10.91K |
| NET LOSS | 34.87K |
| Weighted average common shares outstanding: | |
| Basic (in shares) | 4.18M |
| Diluted (in shares) | 4.3M |
| NET LOSS PER SHARE: | |
| Basic (in dollars per share) | 0.01 |
| Diluted (in dollars per share) | 0.01 |
Entities mentioned with ICCC
- Earnings | View Related Stories »
- FDA | View Related Stories »
- S3 | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- 13D | View Related Stories »
- Trading Radar | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Show More...
